In this “Cancer in My Community” post, Dr. Carlos Barrios discusses why he was drawn to oncology, the disparities that exist in cancer care in Brazil, why expanding access to clinical trials is so important, and resources available to help those with cancer in Brazil.
Dr. Manali I. Patel discusses what people with cancer should know about getting access to advances presented at scientific meetings, including questions to ask your health care team, why access to new advances may not be available right away, and how to get involved with cancer research.
In this post, stage IV melanoma survivor Tzvia Bader shares what it was like navigating treatment decision-making, how she became an active part of her care and found clinical trials to participate in, and her advice for other people with cancer on doing the same.
In this post, several experts describe the importance of peer-reviewed cancer information, including what “peer reviewed” means, what to know about levels of scientific evidence in cancer research, and the differences between research done in cell lines, animals, and humans.
In this podcast, experts discuss what people with early-stage lung cancer should know about molecular testing, including what it is, how it may be used in guiding treatment decisions, and several recent studies about its role in treatment planning.
La Reunión Anual de la American Society of Clinical Oncology (Sociedad Estadounidense de Oncología Clínica) de 2022 se llevará a cabo del 3 al 7 de junio. En esta publicación inicial de la investigación que se presenta en la reunión, los estudios examinan cómo la raza, el origen étnico, la pobreza y otros factores sociales y demográficos afectan la vida de las personas con cáncer.
The 2022 ASCO Annual Meeting is being held June 3 to 7. In this early release of research being presented at the meeting, studies examine how race, ethnicity, poverty, and other social and demographic factors affect the lives of people with cancer.
In this month’s “From the Editor in Chief” column, Dr. Jyoti Patel discusses the disparities that exist in cancer clinical trials and how cancer care providers are working to address the barriers to participation in clinical trials for minority populations.
Patient advocate Patty Spears discusses what eligibility criteria for cancer clinical trials are, why they’re important to cancer research, and how eligibility criteria are changing to include more people with cancer in clinical trials.
The ASCO Annual Meeting begins on June 4, and here is some of the notable research that will be presented. Topics include combined immunotherapy for esophageal cancer, targeted radiation for mCRPC, olaparib for HER2-negative breast cancer, adjuvant chemotherapy for cervical cancer, pembrolizumab for kidney cancer, and toripalimab for nasopharyngeal cancer.
